QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia.

‣ Subjects are 18 years or older in age

⁃ Subjects must be able to read and understand the study information.

⁃ Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

⁃ Subject is willing and able to comply with the scheduled visits, questionnaires, treatment plan, and other study procedures.

• Suspected CPs Inclusion Criteria

‣ Subjects are 18 years or older in age

⁃ Subjects with a) Indeterminate CP (Cambridge 1 or 2 on CT scan or MRI/MRCP) who have abdominal pain without prior history of AP, or b) those with acute (AP) or recurrent acute pancreatitis (RAP) who have recovered from their attack(s) of AP, whose imaging studies are either normal or show changes consistent with Cambridge classification of 1 or 2, and they have ongoing abdominal pain. Both diabetic and non-diabetic subjects will be allowed to enter the study.

⁃ Subjects must be able to read and understand the study information.

⁃ Subjects must suffer from abdominal pain suspected to be pancreatic origin with an intensity above 3 on the visual analogue scale (VAS, where 0=no pain and 10= intolerable pain), and meet the criteria for chronic pain (pain ≥ 3 days per week for at least 3 months).

⁃ Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

⁃ Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures.

• Definite Chronic Pancreatitis - Inclusion Criteria

‣ Subjects are 18 years or older in age

⁃ Subjects will have a prior confirmed diagnosis of CP on CT scan or MRI/MRCP according to Cambridge Classification (grade 3 or 4). Both diabetic and non-diabetic subjects will be allowed to enter the study.

⁃ Subjects must be able to read and understand the study information.

⁃ Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

⁃ Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures.

• Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Inclusion Criteria

‣ Subjects are 18 years or older in age

⁃ Subjects have prior diagnosis of Type 1 or Type 2 Sphincter of Oddi Dysfunction (subjects with biliary pain accompanied by biochemical features of transient biliary tract obstruction including elevated transaminases, alkaline phosphatase, or conjugated bilirubin; may also be accompanied by biliary or pancreatic ductal dilation on imaging)

⁃ Subjects must be able to read and understand the study information.

⁃ Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

⁃ Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures.

Locations
United States
Indiana
Indiana University Medical Center
RECRUITING
Indianapolis
Maryland
Johns Hopkins Medical Institutions
RECRUITING
Baltimore
Pennsylvania
University of Pittsburgh Medical Center
RECRUITING
Pittsburgh
Contact Information
Primary
Anna Evans-Phillips, MD
evansac3@upmc.edu
412-624-4560
Backup
Apsara Mishra
apm179@pitt.edu
Time Frame
Start Date: 2017-10-24
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 500
Treatments
Active_comparator: Healthy Controls
Subjects with no pancreatic disease and no abdominal pain.~Subjects will undergo the following Interventions:~Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.
Active_comparator: Suspected CP
Suspected Chronic Pancreatitis patients.~Subjects will undergo the following Interventions:~Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.
Active_comparator: Definite CP
Definite Chronic Pancreatitis patients.~Subjects will undergo the following Interventions:~Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.~A subset of these patients who undergo endotherapy as per clinical recommendation from clinical provider independent of this study will be followed for 6 months after their clinical intervention for repeat Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3 and questionnaires.
Active_comparator: Sphincter of Oddi Dysfunction or Functional Dyspepsia
Patients with Sphincter of Oddi Dysfunction Type 1 or Type 2, or who have a prior diagnosis of Functional Dyspepsia.~Subjects will undergo the following Interventions:~Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.
Authors
Benjamin Lo Bick, Dhiraj Yadav, Anna E Phillips
Sponsors
Leads: Anna Evans Phillips
Collaborators: Aalborg University, Johns Hopkins University

This content was sourced from clinicaltrials.gov